Showing results (101-110 of 212) with videos related to

Sort By:
Pageof 22
Antimicrobial Agents and Chemotherapy|July 25, 2022
Therapeutic Drug Monitoring of Orally Administered Letermovir Prophylaxis in Allogeneic Hematopoietic Stem Cell Transplant RecipientsLéna Royston, Stavroula Masouridi-Levrat, Verena Gotta, et al.
Transplantation and Cellular Therapy|August 11, 2022
Defibrotide Shows Efficacy in the Prevention of Sinusoidal Obstruction Syndrome After Allogeneic Hematopoietic Stem Cell Transplantation: A Retrospective StudyYves Chalandon, Anne-Claire Mamez, Federica Giannotti, et al.
Open Forum Infectious Diseases|April 28, 2025
Blood Virome After Allogeneic Hematopoietic Stem Cell TransplantationKrisztina Hosszu-Fellous, Samuel Cordey, Stavroula Masouridi-Levrat, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|August 26, 2018
Incidence and outcome of invasive fungal diseases after allogeneic hematopoietic stem cell transplantation: A Swiss transplant cohort studySabine Kuster, Susanne Stampf, Bernhard Gerber, et al.
Bulletin Du Cancer|September 6, 2025
[Acute graft-versus-host disease therapy: Which third line treatment after steroids and ruxolitinib? (SFGM-TC)]Tereza Coman, Fabio Andreozzi, Jaques-Olivier Bay, et al.
Plos One|August 27, 2013
The clinical relevance of pre-formed anti-HLA and anti-MICA antibodies after cord blood transplantation in childrenMarc Ansari, Chakradhara Rao S Uppugunduri, Sylvie Ferrari-Lacraz, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 11, 2012
Long-term follow-up of the imatinib GRAAPH-2003 study in newly diagnosed patients with de novo Philadelphia chromosome-positive acute lymphoblastic leukemia: a GRAALL studyAline Tanguy-Schmidt, Philippe Rousselot, Yves Chalandon, et al.
Pageof 22